发明名称 STRATEGY FOR RETROVIRAL IMMUNOTHERAPY
摘要 <p>The present inventor has noted that at least two populations of immune cells are produced in response to retroviruses which infect mammals. More particularly, the immune system of a mammal infected with a retrovirus is capable of mounting an immune response against the virus through a group of cells herein generally referred to as "effector cells", however, a second population of cells are also produced which regulate the "effector cells", herein generally referred to as "regulator cells" or suppressor cells, limiting the mammal's ability to effectively control or eradicate the retroviral infection. Accordingly, the present invention utilizes these observations to provide methods for treating a mammal with a retroviral infection. Furthermore, the present inventor has found that acute phase inflammatory markers can be used to detect and monitor an"effector cell" response to retroviral antigens.</p>
申请公布号 WO03070270(A1) 申请公布日期 2003.08.28
申请号 WO2003AU00207 申请日期 2003.02.18
申请人 IMMUNAID PTY LTD;ASHDOWN, MARTIN, LEONARD 发明人 ASHDOWN, MARTIN, LEONARD
分类号 C07D519/04;A61K31/475;A61K39/00;A61K39/21;A61K39/39;A61K45/06;A61P31/14;A61P31/18;(IPC1-7):A61K39/00 主分类号 C07D519/04
代理机构 代理人
主权项
地址